会員登録
ログイン
【4572】カルナバイオサイエンス
創薬支援。
類似企業：
【業界1位】
小野薬品工業
【業界1位】
小野薬品工業
売上高
営業利益
経常利益
当期利益
業績予想修正
対前回修正率
当初予想比較
| 決算期 | 日付 | 予・実 | 売上高 (百万円) | 対前回 | 営業利益 (百万円) | 対前回 | 経常利益 (百万円) | 対前回 | 当期利益 (百万円) | 対前回 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025.12 | 2025/02/10 | 当初予 | 722 | - | -2,133 | - | -2,137 | - | -2,147 | - |
| 2024.12 | 2025/02/10 | 実 | 636 | ↑ | -2,076 | ↑ | -2,080 | ↑ | -2,178 | ↑ |
| 2024.12 | 2024/12/19 | 修正予 | 630 | ↓ | -2,153 | ↑ | -2,168 | ↑ | -2,180 | ↑ |
| 2024.12 | 2024/11/08 | Q3予 | 925 | → | -2,201 | → | -2,208 | → | -2,225 | → |
| 2024.12 | 2024/08/07 | Q2予 | 925 | → | -2,201 | → | -2,208 | → | -2,225 | → |
| 2024.12 | 2024/05/10 | Q1予 | 925 | → | -2,201 | → | -2,208 | ↓ | -2,225 | → |
| 2024.12 | 2024/02/09 | 当初予 | 925 | - | -2,201 | - | -2,201 | - | -2,225 | - |
| 2023.12 | 2024/02/09 | 実 | 1,625 | ↑ | -1,116 | ↑ | -1,126 | ↑ | -1,152 | ↑ |
| 2023.12 | 2023/12/14 | 修正予 | 1,610 | ↑ | -1,183 | ↑ | -1,203 | ↑ | -1,229 | ↑ |
| 2023.12 | 2023/11/07 | Q3予 | 902 | → | -1,890 | → | -1,911 | → | -1,936 | → |
| 2023.12 | 2023/08/07 | Q2予 | 902 | → | -1,890 | → | -1,911 | → | -1,936 | → |
| 2023.12 | 2023/05/10 | Q1予 | 902 | → | -1,890 | → | -1,911 | ↓ | -1,936 | → |
| 2023.12 | 2023/02/10 | 当初予 | 902 | - | -1,890 | - | -1,890 | - | -1,936 | - |
| 2022.12 | 2023/02/10 | 実 | 1,386 | ↑ | -1,269 | ↑ | -1,278 | ↑ | -1,349 | ↑ |
| 2022.12 | 2022/12/14 | 修正予 | 1,363 | ↑ | -1,451 | ↑ | -1,451 | ↑ | -1,513 | ↑ |
| 2022.12 | 2022/11/07 | Q3予 | 1,186 | → | -1,672 | → | -1,685 | → | -1,740 | → |
| 2022.12 | 2022/08/05 | Q2予 | 1,186 | → | -1,672 | → | -1,685 | → | -1,740 | → |
| 2022.12 | 2022/05/10 | Q1予 | 1,186 | ↑ | -1,672 | ↑ | -1,685 | ↑ | -1,740 | ↑ |
| 2022.12 | 2022/02/10 | 当初予 | 1,127 | - | -1,730 | - | -1,730 | - | -1,799 | - |
| 2021.12 | 2022/02/10 | 実 | 2,017 | ↑ | -531 | ↑ | -522 | ↑ | -534 | ↑ |
| 2021.12 | 2021/12/23 | 修正予 | 2,006 | ↑ | -548 | ↑ | -552 | ↑ | -560 | ↑ |
| 2021.12 | 2021/11/08 | Q3予 | 923 | → | -1,811 | → | -1,816 | → | -1,825 | → |
| 2021.12 | 2021/08/06 | Q2予 | 923 | → | -1,811 | → | -1,816 | ↓ | -1,825 | → |
| 2021.12 | 2021/05/10 | Q1予 | 923 | → | -1,811 | → | -1,811 | → | -1,825 | → |
| 2021.12 | 2021/02/12 | 当初予 | 923 | - | -1,811 | - | -1,811 | - | -1,825 | - |
| 2020.12 | 2021/02/12 | 実 | 1,133 | ↑ | -1,057 | ↑ | -1,077 | ↑ | -1,111 | ↑ |
| 2020.12 | 2020/12/08 | 修正予 | 1,103 | ↑ | -1,190 | ↑ | -1,202 | ↑ | -1,229 | ↑ |
| 2020.12 | 2020/11/09 | Q3予 | 1,036 | → | -1,779 | → | -1,794 | → | -1,822 | → |
| 2020.12 | 2020/08/07 | Q2予 | 1,036 | → | -1,779 | → | -1,794 | ↓ | -1,822 | → |
| 2020.12 | 2020/05/12 | Q1予 | 1,036 | → | -1,779 | → | -1,779 | → | -1,822 | → |
| 2020.12 | 2020/02/07 | 当初予 | 1,036 | - | -1,779 | - | -1,779 | - | -1,822 | - |
| 2019.12 | 2020/02/07 | 実 | 3,207 | ↑ | 977 | ↑ | 957 | ↑ | 828 | ↑ |
| 2019.12 | 2020/01/09 | 修正予 | 3,206 | ↑ | 968 | ↑ | 951 | ↑ | 791 | ↑ |
| 2019.12 | 2019/11/08 | Q3予 | 3,038 | → | 313 | → | 279 | → | 214 | → |
| 2019.12 | 2019/08/13 | Q2予 | 3,038 | → | 313 | → | 279 | → | 214 | → |
| 2019.12 | 2019/06/25 | 修正予 | 3,038 | ↑ | 313 | ↑ | 279 | ↑ | 214 | ↑ |
| 2019.12 | 2019/05/13 | Q1予 | 1,240 | → | -1,658 | → | -1,658 | ↑ | -1,693 | → |
| 2019.12 | 2019/02/08 | 当初予 | 1,240 | - | -1,658 | - | -1,671 | - | -1,693 | - |
| 2018.12 | 2019/02/08 | 実 | 754 | ↑ | -1,144 | ↓ | -1,159 | ↓ | -1,210 | ↓ |
| 2018.12 | 2018/12/20 | 修正予 | 753 | ↓ | -1,136 | ↓ | -1,152 | ↓ | -1,204 | ↓ |
| 2018.12 | 2018/11/09 | Q3予 | 1,190 | → | -679 | → | -694 | → | -758 | → |
| 2018.12 | 2018/08/06 | Q2予 | 1,190 | → | -679 | → | -694 | → | -758 | → |
| 2018.12 | 2018/05/11 | Q1予 | 1,190 | → | - | - | -694 | ↓ | -758 | → |
| 2018.12 | 2018/02/09 | 当初予 | 1,190 | - | -679 | - | -679 | - | -758 | - |
| 2017.12 | 2018/02/09 | 実 | 657 | ↓ | -699 | ↑ | -711 | ↑ | -737 | ↑ |
| 2017.12 | 2017/11/10 | Q3予 | 701 | ↓ | -727 | ↓ | -738 | ↓ | -766 | ↓ |
| 2017.12 | 2017/08/07 | Q2予 | 1,440 | → | 39 | → | 35 | ↓ | 6 | → |
| 2017.12 | 2017/05/12 | Q1予 | 1,440 | → | 39 | → | 39 | → | 6 | → |
| 2017.12 | 2017/02/10 | 当初予 | 1,440 | - | 39 | - | 39 | - | 6 | - |
| 2016.12 | 2017/02/10 | 実 | 811 | ↑ | -423 | ↑ | -440 | ↑ | -289 | ↑ |
| 2016.12 | 2016/12/16 | 当初予 | 804 | - | -432 | - | -449 | - | -299 | - |
| 2015.12 | 2016/02/12 | 実 | 1,569 | ↑ | 472 | ↑ | 492 | ↑ | 456 | ↑ |
| 2015.12 | 2015/11/06 | Q3予 | 1,532 | → | 372 | → | 395 | → | 364 | → |
| 2015.12 | 2015/08/07 | Q2予 | 1,532 | → | 372 | → | 395 | → | 364 | → |
| 2015.12 | 2015/07/28 | 当初予 | 1,532 | - | 372 | - | 395 | - | 364 | - |
| 2014.12 | 2015/02/13 | 実 | - | - | - | - | - | - | - | - |
| 2014.12 | 2014/12/19 | 当初予 | 610 | - | -640 | - | -613 | - | -853 | - |
| 2013.12 | 2014/02/07 | 実 | 771 | - | -300 | - | -276 | - | -282 | - |
